These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The diagnosis and treatment of the hyperlipoproteinemias: emphasis on Types IIa, IIb and IV. Frommeyer WB Ala J Med Sci; 1974 Jul; 11(3):207-14. PubMed ID: 4375414 [No Abstract] [Full Text] [Related]
26. Stress perfusion-fibrosis cardiac magnetic resonance detects early heart involvement in young asymptomatic, homozygous familial hyperlipidemia with normal routine non-invasive evaluation. Mavrogeni S; Bratis K; Papachristou P; Giannakopoulou E; Karanasios E; Kolovou G; van Wijk K; Hautemann D; Reiber JH; Papadopoulos G Int J Cardiol; 2013 Oct; 168(4):4570-2. PubMed ID: 23896536 [No Abstract] [Full Text] [Related]
27. Persistent elevation of the erythrocyte sedimentation rate (ESR) in familial hypercholesterolemia. With a preliminary report on the effect of plasma beta-lipoproteins on ESR. Khachadurian AK; Demirjian ZN J Med Liban; 1967; 20(1):31-43. PubMed ID: 6080559 [No Abstract] [Full Text] [Related]
28. Very High Cholesterol Mimicking Homozygous Familial Hypercholesterolemia. Shotwell MK; Vorla M; Kalra DK Circulation; 2022 Oct; 146(15):1182-1188. PubMed ID: 36214132 [No Abstract] [Full Text] [Related]
29. Cholesterol at birth and age 1: comparison of normal and hypercholesterolemic neonates. Tsang RC; Fallat RW; Glueck CJ Pediatrics; 1974 Apr; 53(4):458-70. PubMed ID: 4362901 [No Abstract] [Full Text] [Related]
30. Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia. Fernández-Fuertes LF; Tapia Martín M; Nieves Plá I; Novoa Mogollón FJ; Díaz Cremades J Ther Apher Dial; 2010 Oct; 14(5):484-5. PubMed ID: 21175548 [No Abstract] [Full Text] [Related]
31. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques. Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771 [No Abstract] [Full Text] [Related]
32. Are selective macromolecule removal plasmapheresis systems useful for autoimmune diseases or hyperlipidemia? Malchesky PS; Kaplan A; Koo AP; Sakurada Y; Siami GA ASAIO J; 1993; 39(4):868-72. PubMed ID: 8123919 [TBL] [Abstract][Full Text] [Related]
33. [Familial hyperlipoproteinemia type IIA with homozygotic manifestations in a heterozygote]. Traurig J; Sobra J; Kvasilová M; Wildtová Z Vnitr Lek; 1978 Jul; 24(7):684-90. PubMed ID: 209627 [No Abstract] [Full Text] [Related]
34. [Familial hypercholesterolemia: clinical findings and immunochemical studies of lipoproteins]. Kobierska-Szczepańska A; Dziuba P; Szczepański Z Pediatr Pol; 1976 Dec; 51(12):1435-41. PubMed ID: 188008 [No Abstract] [Full Text] [Related]
35. [Diet therapy of hyperlipemias]. Russo F G Clin Med; 1971 Apr; 52(4):317-29. PubMed ID: 5121124 [No Abstract] [Full Text] [Related]
36. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants. Yeh JH; Lee MF; Chiu HC J Clin Apher; 2003; 18(1):32-6. PubMed ID: 12717791 [TBL] [Abstract][Full Text] [Related]
37. The first 6 years of the Tygerberg Hospital lipid clinic. Jooste PL; Oelofse A; Wolmarans P; Steyn K; Weich HF; Kriek JA S Afr Med J; 1992 Feb; 81(3):135-9. PubMed ID: 1734550 [TBL] [Abstract][Full Text] [Related]
38. [Should one treat hyperlipidemia in diabetes, and how?]. Moulin P; Berthezene F Diabete Metab; 1990; 16(3):252-6. PubMed ID: 2210022 [No Abstract] [Full Text] [Related]
39. [Classification and diet therapy of hyperlipemia]. Heyden S Dtsch Med Wochenschr; 1974 Jan; 99(4):141-4. PubMed ID: 4358872 [No Abstract] [Full Text] [Related]
40. Therapy of homozygous type IIA familial hypercholesterolemia using special on line plasma filter pheresis. Siami G; Hakim R Prog Clin Biol Res; 1990; 337():209-12. PubMed ID: 2352978 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]